Daniel E. Geffken
Overview
Daniel E. Geffken received an average of $97K in total compensation at Sevion Therapeutics between 2021 and 2022. Daniel Geffken also received $136K at Marina Biotech in 2014.
Source: SEC filings on April 28, 2023 and September 29, 2015.
Related executives
We found 24 more executives who work or worked at Sevion Therapeutics and Marina Biotech.
Sumit Aggarwal
Sevion Therapeutics
Chief Executive Officer
Vijay Modur
Sevion Therapeutics
Head of Research and Development
Gregory Williams
Sevion Therapeutics
Chief Operating Officer
Robert Ward
Sevion Therapeutics
Chief Executive Officer
David Snow
Sevion Therapeutics
Chief Business Officer
Gregory Weaver
Sevion Therapeutics
Chief Financial Officer
Robert Moscato
Marina Biotech
Chief Executive Officer
Vuong Trieu
Marina Biotech